Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-12-03
1991-12-31
Barr, Josephine
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514262, A01N 4390
Patent
active
050772961
ABSTRACT:
A method of treating a horse suffering from navicular disease which involves administering an amount of a composition including pentoxifylline in a daily dose for a sufficient period of time effective to alleviate lameness in horses resulting from navicular disease. A pharmaceutical composition including an effective amount of pentoxifylline and a pharmaceutically acceptable carrier for alleviating lameness resulting from navicular disease.
REFERENCES:
patent: 3928609 (1975-12-01), Behrakis
patent: 4383997 (1983-05-01), Boucher
patent: 4460772 (1984-07-01), Benovic et al.
patent: 4500530 (1985-02-01), Boucher
patent: 4511557 (1985-04-01), Gauri
patent: 4975432 (1990-12-01), Weithmann et al.
Barr Josephine
Hyal Pharmaceutical Corporation
LandOfFree
Method for treating equine navicular disease with pentoxifylline does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating equine navicular disease with pentoxifylline, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating equine navicular disease with pentoxifylline will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1510427